Gefitinib plus docetaxel in non-small-cell lung cancer
- PMID: 19217981
- DOI: 10.1016/S0140-6736(09)60192-6
Gefitinib plus docetaxel in non-small-cell lung cancer
Comment on
-
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.Lancet. 2008 Nov 22;372(9652):1809-18. doi: 10.1016/S0140-6736(08)61758-4. Lancet. 2008. PMID: 19027483 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous